Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration
CRISPR-Cas13 systems have therapeutic promise for the precise correction of point mutations in RNA. Using adenosine deaminase acting on RNA (ADAR) effectors, A-I base conversions can be targeted using guide RNAs (gRNAs). We compare the Cas13 effectors PspCas13b and Cas13bt3 for the repair of the gen...
Main Authors: | Fry, LE, Major, L, Salman, A, McDermott, LA, Yang, J, King, AJ, McClements, ME, MacLaren, RE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Research
2025
|
Similar Items
-
Development of CRISPR gene therapy for retinal degenerations
by: Fry, LE
Published: (2021) -
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing
by: Chin, Jiah Shin, et al.
Published: (2020) -
CRISPR-Cas9-mediated gene editing of MYB28 genes impair glucoraphanin accumulation of Brassica oleracea in the field
by: Neequaye, M, et al.
Published: (2021) -
Molecular dynamics study on the mechanism of high-fidelity CRISPR-Cas9 system
by: Liu, Zhehui
Published: (2017) -
Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis
by: Lee, Raymond Teck Ho, et al.
Published: (2016)